Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Multiple Allele Traits01:49

Multiple Allele Traits

38.2K
The Concept of Multiple Allelism
38.2K
Induction01:16

Induction

5.8K
An emf is induced when the magnetic field in a coil is changed by pushing a bar magnet into or out of the coil. emfs of opposite signs are produced by motion in opposite directions, and the directions of emfs are also reversed by reversing poles. The same results are produced if the coil is moved rather than the magnet—it is the relative motion that is important. The faster the motion, the greater the emf. Additionally, there is no emf when the magnet is stationary relative to the coil.
A...
5.8K
Self-Inductance01:24

Self-Inductance

3.1K
Mutual inductance arises when a current in one circuit produces a changing magnetic field that induces an emf in another circuit. On the other hand, self-inductance arises when the current passing through the circuit changes, creating a changing magnetic flux, resulting in inductance in the same circuit.
Consider a circuit connected to an AC source. As the current varies with time, the magnetic flux through the circuit correspondingly changes. Faraday's law tells us that an emf would...
3.1K
Group Therapy01:26

Group Therapy

454
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
454
Multiple Regression01:25

Multiple Regression

4.0K
Multiple regression assesses a linear relationship between one response or dependent variable and two or more independent variables. It has many practical applications.
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in the real-world management of patients with active relapsing-remitting multiple sclerosis treated with natalizumab (TYSABRI®) in France: An analysis of the PMSI database over five years (2019-2023).

Revue neurologique·2025
Same author

Determinants of the experience of patients living with multiple sclerosis in terms of care pathway quality: An original French study.

Revue neurologique·2025
Same author

Ureaplasma urealyticum septic hip arthritis associated with ocrelizumab therapy in a young patient with multiple sclerosis.

Revue neurologique·2025
Same author

Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient.

Revue neurologique·2024
Same author

Dyadic coping strategies and quality of care experience: An original study of patients living with multiple sclerosis and their caregivers.

Revue neurologique·2023
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022

Related Experiment Video

Updated: Feb 10, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K

Induction or escalation therapy for patients with multiple sclerosis?

E Le Page1, G Edan1

  • 1CIC-P 02-03 Inserm, INCR, Department of neurology, CHU de Rennes, 2, rue Henri-le-Guilloux, 35000 Rennes, France.

Revue Neurologique
|May 26, 2018
PubMed
Summary

Induction therapy, followed by maintenance, offers sustained control for aggressive multiple sclerosis (MS). Drugs like mitoxantrone, alemtuzumab, and cladribine show long-term benefits, particularly in early disease stages.

Keywords:
DrugsEscalationInductionMultiple sclerosisStrategy

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.1K
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

18.1K

Related Experiment Videos

Last Updated: Feb 10, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.1K
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

18.1K

Area of Science:

  • Neurology
  • Immunology
  • Pharmacology

Background:

  • The induction-maintenance treatment concept has been explored for multiple sclerosis (MS) for over 30 years.
  • Early strategies combined induction with mitoxantrone and maintenance with immunomodulators like interferon-β or glatiramer acetate.
  • Long-term studies show this regimen rapidly reduces disease activity and sustains control in 60% of patients for up to five years.

Purpose of the Study:

  • To evaluate the efficacy and suitability of different disease-modifying drugs (DMDs) for multiple sclerosis (MS) based on induction or escalation strategies.
  • To compare the long-term benefits of induction therapies (mitoxantrone, alemtuzumab, cladribine) versus continuous immunosuppression (natalizumab, ocrelizumab).
  • To propose treatment algorithms for MS management considering disease course and activity.

Main Methods:

  • Review of randomized controlled trials and long-term observational studies of MS treatments.
  • Analysis of treatment response and safety profiles of mitoxantrone, alemtuzumab, cladribine, natalizumab, and ocrelizumab.
  • Development of proposed algorithms for MS treatment strategies.

Main Results:

  • Mitoxantrone and alemtuzumab demonstrated long-term disease control in a subset of patients with early, aggressive MS.
  • Alemtuzumab showed superiority over interferon-β in Phase II/III studies, with sustained benefits for up to 7 years.
  • Cladribine exhibited potential induction effects with sustained low disease activity for up to 4 years.
  • Continuous immunosuppressants like natalizumab and ocrelizumab are effective but require ongoing treatment, unlike induction therapies.

Conclusions:

  • Induction therapies (mitoxantrone, alemtuzumab, cladribine) offer sustained benefits, particularly for early, aggressive MS, due to a remnant effect.
  • Continuous immunosuppression is effective but lacks the long-term residual benefit of induction strategies.
  • Treatment algorithms should consider individual disease course and activity to optimize the choice between induction and escalation strategies.